<DOC>
	<DOCNO>NCT01528176</DOCNO>
	<brief_summary>To determine whether chronic kidney disease ( CKD ) , stag III—V ESRD , associate alter vitamin D metabolism relate fibroblast growth factor-23 ( FGF-23 ) stimulation Cyp24 whether resistance elevation 25 Hydroxyvitamin D ( 25 ( OH ) D3 ) cholecalciferol supplementation . To determine resistance relate enhance catabolism ( 25 ( OH ) relate elevated level FGF-23 .</brief_summary>
	<brief_title>Vitamin D Metabolism Chronic Kidney Disease Patients</brief_title>
	<detailed_description>1 . Patients Memphis VA Medical Center document vitamin D deficiency , determine measurement 25 ( OH ) D3 , recruit study . 25 ( OH ) D3 measurement commonly obtain routine clinical care primary care nephrology clinic . Patient wide range kidney function , range normal estimate glomerular filtration rate ( e GFR ) patient stage III V ( CKD ) ( estimate GFR &lt; 60 ml/min ) recruit treated weekly oral administration 10,000 IU cholecalciferol total 8 week order correct vitamin D deficiency . 2 . Data collect : Baseline characteristic include demographic , laboratory data obtain primary care clinic visit , clinical data VAMC medical record medication obtain time inclusion study . Serum concentration FGF23 , 25 ( OH ) D , 1,25 dihydroxyvitamin D ( 1,25 ( OH ) ₂D ) , 24,25 dihydroxyvitamin D ( 24,25 ( OH ) ₂D ) , intact parathyroid hormone ( PTH ) , Calcium , Phosphorous creatinine urinary concentration calcium , phosphate creatinine 24 hr urine collection obtain time inclusion study 8 week weekly cholecalciferol therapy . Serum buffy coat recollect dialysis patient 's agreed participate , use measure mRNA level FGF-23 , CPY27B1 Cyp 24 expression . 3 . Methods utilized analyze interpret data Descriptive statistic perform compare serum urinary measurement cholecalciferol therapy . Associations estimate glomerular filtration rate level vitamin D metabolite FGF23 , treatment , also evaluate . The mRNA expression FGF-23 , CPY27B1 Cyp 24 measure subset dialysis patient complete treatment course agree provide additional sample . 4 . Duration project : 1 year .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>age 1885 year ; CKD stage III V ; serum 25 ( OH ) D level ≤ 30ng/ml , serum PTH level &gt; 70 pg/ml within last 6 month , inform Consent . A history liver disease , sarcoidosis , intestinal malabsorption ; requirement dialysis study ; serum calcium level &gt; 10.5 mg/dl , calciumphosphorus product &gt; 70 , calcimimetics , phosphorus binder ; medication could affect vitamin D metabolism history parathyroidectomy .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>FGF-23 , CKD , Cyp24 , 24,25 ( OH ) 2D , vitamin D metabolism</keyword>
</DOC>